Trial intelligence / Profile preview

Chronos: Radiochemotherapy in Elderly Esophagus Cancer

NCT02879227Phase 2Completed

Sponsor
CHU de Besançon
Start
Jan 2010
Primary completion
Dec 2014
Modality
DNA Intercalators/Alkylators
01

Overview

A Phase 2 trial of oxaliplatin in esophageal cancer, sponsored by CHU de Besançon. Started Jan 2010; status: completed.

02

Drugs

oxaliplatin
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT02879227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02879227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call